NYX Nyse Euronext

NYSE Euronext (NYX) today announced trading volumes for its global derivatives and cash equities exchanges for September 20101. Global derivatives average daily volume (“ADV”) of 7.7 million contracts traded per day in September 2010 increased 4.8% versus the prior year and increased 22.5% from August 2010 levels. The increase in global derivatives ADV versus prior year levels was driven by a 15.9% increase in U.S. equity options ADV, partially offset by a 2.7% decrease in European derivatives ADV. Cash equities ADV in September 2010 were down, with European and U.S. cash trading volumes decreasing 5.2% and 24.6%, respectively, compared to prior year levels.

1 All NYSE Euronext derivatives transactions count buy and sell orders together as a single transaction. NYSE Euronext European equities transactions count each buy and sell order as separate transactions, NYSE Euronext U.S. equities transactions count buy and sell orders together as a single transaction.

Highlights

• NYSE Euronext global derivatives ADV in September 2010 of 7.7 million contracts increased 4.8% compared to September 2009 and increased 22.5% from August 2010 levels. Open interest for our European derivatives businesses at the end of September 2010 was 76.9 million contracts, a decrease of 0.7% compared to September 2009. European derivatives fixed income open interest of 25.1 million contracts was up 7.7% compared to September 2009.
• NYSE Euronext European derivatives products ADV in September 2010 of 4.2 million contracts decreased 2.7% compared to September 2009, but increased 28.8% from August 2010 levels. Total European fixed income products ADV in September 2010 of 2.2 million contracts decreased 2.3% compared to September 2009, but increased 35.9% from August 2010. Total equity products ADV of 1.9 million contracts in September 2010 decreased 4.4% compared to September 2009, but increased 23.2% from August 2010. Total commodities products ADV of 77,000 contracts in September 2010 increased 47.8% compared to September 2009.
• NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 3.5 million contracts in September 2010 increased 15.9% compared to September 2009 levels and increased 15.5% from August 2010. NYSE Euronext’s U.S. options exchanges accounted for 26.1% of the total consolidated equity options trading in September 2010, up from 21.4% in September 2009 and up from the 25.2% recorded in August 2010.
• NYSE Euronext European cash products ADV of 1.4 million transactions in September 2010 decreased 5.2% compared to September 2009, but increased 9.5% from August 2010.
• NYSE Euronext U.S. cash products (NYSE, NYSE Arca and NYSE Amex) handled ADV of 2.3 billion shares in September 2010 decreased 24.6% compared to September 2009 and decreased 0.8% compared to August 2010. NYSE Euronext’s Tape A matched market share in September 2010 was 38.4%, up from 36.1% in September 2009 and up from 38.1% in August 2010.
• There were a total of 22 trading days in Europe and 21 trading days the U.S. in September 2010 and September 2009, respectively.
• The estimated average net revenue per transaction type (as defined below) for each of the primary trading venues in the third quarter of 2010 is included below:

                2Q10 Actual   3Q10 Estimate European Derivatives (ex. Bclear)1 $0.64 $0.65 U.S. Equity Options2 $0.17 $0.17 European Cash3 $0.65 $0.66 U.S. Cash4   $0.030  

$0.031

1 Average net revenue per contract, excluding Bclear.2 Average net revenue per contract.3 Average net revenue per transaction.4 Average net revenue per 100 shares handled.

Derivatives Trading

European Derivatives

• NYSE Euronext European derivatives products ADV in September 2010 was 4.2 million futures and options contracts, a decrease of 2.7% from September 2009, but an increase of 28.8% from August 2010. The 4.2 million in futures and options contracts ADV in September 2010 consisted of 3.3 million contracts executed through our full-service LIFFE CONNECT trading platform and 0.9 million contracts, or 21.1%, executed through Bclear, NYSE Liffe's trade administration and clearing service for OTC products. In the third quarter of 2010, European derivatives products ADV of 3.8 million contracts was 0.6% above prior year levels. The 3.8 million in futures and options contracts ADV in the third quarter of 2010 consisted of 3.0 million contracts executed through LIFFE CONNECT trading platform and 0.8 million contracts, or 22.1%, executed through Bclear.
• The anticipated average net rate per contract for European derivatives, excluding Bclear, is expected to be approximately $0.65 per contract in the third quarter of 2010.
• Year-to-date, European derivatives products ADV of 5.1 million contracts was 22.6% above prior year levels. The 5.1 million in futures and options contracts ADV year-to-date consisted of 3.6 million contracts executed through the LIFFE CONNECT trading platform and 1.5 million contracts, or 29.1%, executed through Bclear.
• Total fixed income products ADV of 2.2 million contracts in September 2010 decreased 2.3% from September 2009, but increased 35.8% from August 2010. In the third quarter of 2010, total fixed income products ADV of 2.0 million contracts was 2.3% above prior year levels. Year-to-date, total fixed income products ADV of 2.4 million contracts was 20.8% above prior year levels.
• Total equity products (including Bclear) ADV of 1.9 million contracts in September 2010 decreased 4.4% compared to September 2009, but increased 23.2% from August 2010. The 1.9 million contracts in equity products ADV consisted of 1.3 million contracts in individual equity products ADV and 0.6 million contracts in equity index products ADV. The 1.3 million contracts in individual equity products ADV consisted of 0.7 million in futures contracts, which represented a 19.5% increase compared to September 2009 and 0.6 million in options contracts, which represented a 19.1% decrease compared to September 2009. The average rate per contract for individual equity futures contracts is significantly lower than other products traded on NYSE Liffe. In the third quarter of 2010, total equity products ADV of 1.8 million contracts was 3.1% below prior year levels. Year-to-date, total equity products ADV of 2.6 million contracts was 24.0% above prior year levels.
• Total commodities products ADV of 77,000 contracts in September 2010 increased 47.8% compared to September 2009. In the third quarter of 2010, total commodities product ADV of 81,000 contracts was 74.4% above prior year levels. Year-to-date, total commodities product ADV of 63,000 contracts was 34.2% above prior year levels.

U.S. Derivatives

• NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 3.5 million contracts in September 2010 increased 15.9% compared to September 2009 and increased 15.5% compared to August 2010. In the third quarter of 2010, U.S. equity options ADV of 3.2 million contracts was 23.6% above prior year levels.
• The anticipated average net rate per contract for U.S. equity options is expected to be approximately $0.17 per contract in the third quarter of 2010.
• Year-to-date, U.S. equity options ADV of 3.7 million contracts was 46.9% above prior year levels.
• Total U.S. consolidated equity options ADV decreased 4.8% to 13.3 million contracts in September 2010 compared to September 2009, but increased 11.7% compared to August 2010. In the third quarter of 2010, U.S. consolidated equity options ADV of 12.5 million contracts was 5.6% below prior year levels. Year-to-date, U.S. consolidated equity options ADV of 14.0 million contracts was 3.8% above prior year levels.
• NYSE Euronext’s U.S. options exchanges accounted for 26.1% of the total consolidated equity options trading in September 2010, up from 21.4% in September 2009 and up from 25.2% in August 2010.
• NYSE Euronext U.S. futures and futures options (NYSE Liffe U.S.) ADV in September 2010 was approximately 10,800 contracts, compared to 20,600 contracts in September 2009. In the third quarter of 2010, U.S. futures and futures options ADV was 10,700 contracts. Year-to-date U.S. futures and futures options ADV was 16,600 contracts, an increase of 0.3% compared to the prior year period.

Cash Trading

European Cash

• NYSE Euronext European cash products ADV of 1.4 million transactions in September 2010 decreased 5.2% compared to September 2009, but increased 9.5% compared to August 2010. In the third quarter of 2010, European cash products ADV of 1.4 million transactions was 3.4% above prior year levels.
• SmartPool, the London-based dark pool owned by NYSE Euronext with BNP Paribas SA, HSBC Holdings Plc and JPMorgan Chase & Co., experienced strong growth in the third quarter of 2010 with the number of trades increasing to 855,770 from 3,141 in the third quarter of 2009 and 541,743 in the second quarter of 2010.
• The anticipated average net revenue per transaction for European cash is expected to be approximately $0.66 per transaction in the third quarter of 2010.
• Year-to-date, European cash products ADV of 1.5 million transactions was 7.3% above prior year levels.

U.S. Cash

• NYSE Euronext U.S. cash products handled ADV in September 2010 decreased 24.6% to 2.3 billion shares compared to September 2009 and decreased 0.8% from August 2010. In the third quarter of 2010, U.S. cash products handled ADV was 2.4 billion shares, down 18.1% from prior year levels.
• The anticipated average net revenue per 100 shares handled for U.S. cash is expected to be approximately $0.031 per 100 shares handled in the third quarter of 2010.
• Year-to-date, U.S. cash products handled ADV was 2.7 billion shares, down 22.8% from prior year levels.
• NYSE Euronext’s Tape A matched market share in September 2010 was 38.4%, up from 36.1% in September 2009 and up from 38.1% in August 2010.
• Designated Market Maker participation in NYSE-listed stocks in September 2010 was 9.4%, compared to 9.8% in August 2010 and 9.6% in July 2010. Supplemental Liquidity Provider participation in NYSE-listed stocks in September 2010 was 12.4%, compared to 12.2% in August 2010 and 13.1% in July 2010. DMM and SLP participation pertain only to trading on NYSE.

Exchange Traded Products

• NYSE Euronext U.S. matched exchange-traded products ADV (included in volumes for Tape B and Tape C) of 301 million shares in September 2010 decreased 5.0% compared to September 2009 and decreased 0.2% compared to August 2010. In the third quarter of 2010, NYSE Euronext U.S. matched exchange-traded products ADV of 334 million shares was 0.4% below prior year levels. Year-to-date, NYSE Euronext U.S. matched exchange-traded products ADV of 352 million shares was 27.8% below prior year levels.

Other Metrics

• The average EUR/USD exchange rate for the third quarter of 2010 of $1.29 represented an increase of 1.4% from the second quarter of 2010 and a decrease of 9.7% compared to the third quarter of 2009.
• The average GBP/USD exchange rate for the third quarter of 2010 of $1.55 represented an increase of 3.9% from the second quarter of 2010 and a decrease of 5.5% compared to the third quarter of 2009.

Please click here for the Monthly Transaction Activity Data Table.

About NYSE Euronext

NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With approximately 8,000 listed issues (excluding European Structured Products), NYSE Euronext's equities markets – the New York Stock Exchange, NYSE Euronext, NYSE Amex, NYSE Alternext and NYSE Arca – represent one-third of the world's equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, one of the leading European derivatives businesses and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index, and is the only exchange operator in the S&P 100 index and Fortune 500. For more information, please visit: http://www.nyx.com.

Cautionary Note Regarding Forward-Looking Statements

This press release August contain forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning NYSE Euronext’s plans, objectives, expectations and intentions and other statements that are not historical or current facts. Forward-looking statements are based on NYSE Euronext’s current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause NYSE Euronext’s results to differ materially from current expectations include, but are not limited to: NYSE Euronext’s ability to implement its strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk and U.S. and global competition, and other factors detailed in NYSE Euronext’s reference document for 2009 ("document de référence") filed with the French Autorité des Marchés Financiers (Filed on April 22, 2010 under No. D.10-0304), 2009 Annual Report on Form 10-K and other periodic reports filed with the U.S. Securities and Exchange Commission or the French Autorité des Marchés Financiers. In addition, these statements are based on a number of assumptions that are subject to change. Accordingly, actual results August be materially higher or lower than those projected. The inclusion of such projections herein should not be regarded as a representation by NYSE Euronext that the projections will prove to be correct. This press release speaks only as of this date. NYSE Euronext disclaims any duty to update the information herein.

NYSE Euronext

Monthly Volume Summary

                    Average Daily Volume Total Volume Average Daily Volume Total Volume (Unaudited) Sep-10 Sep-09 % Chg Sep-10 Sep-09 % Chg YTD 2010

% Chg vs.YTD 2009

YTD 2010

% Chg vs.YTD 2009

  Number of Trading Days - European Markets 22 22 22 22 192 192 Number of Trading Days - U.S. Markets 21 21 21 21 188 188   European Derivatives Products (contracts in thousands) 4,238 4,355 -2.7% 93,235 95,817 -2.7% 5,083 22.6% 975,899 23.2% of which Bclear 893 842 6.0% 19,648 18,531 6.0% 1,479 38.1% 284,009 38.8%   Total Fixed Income Products 2,229 2,282 -2.3% 49,048 50,210 -2.3% 2,436 20.8% 467,703 21.4%   Short Term Interest Rate Products 2,110 2,182 -3.3% 46,413 48,006 -3.3% 2,320 21.0% 445,381 21.6% Medium and Long Term Interest Rate Products 1 120 100 19.5% 2,635 2,205 19.5% 116 17.4% 22,322 18.0%   Total Equity Products 2 1,932 2,021 -4.4% 42,494 44,462 -4.4% 2,584 24.0% 496,067 24.6%   Individual Equity Products 1,319 1,350 -2.3% 29,021 29,699 -2.3% 1,959 33.5% 376,046 34.2% Futures 703 589 19.5% 15,475 12,949 19.5% 1,266 52.9% 242,981 53.7% Options 616 761 -19.1% 13,545 16,750 -19.1% 693 8.5% 133,065 9.0% Equity Index Products 612 671 -8.7% 13,474 14,762 -8.7% 625 1.3% 120,021 1.8%   of which Bclear 893 842 6.0% 19,648 18,531 6.0% 1,479 38.1% 284,009 38.8% Individual Equity Products 792 687 15.3% 17,427 15,112 15.3% 1,381 47.0% 265,069 47.8% Futures 701 585 19.8% 15,432 12,879 19.8% 1,261 53.6% 242,099 54.4% Options 91 101 -10.7% 1,995 2,233 -10.7% 120 1.3% 22,969 1.8% Equity Index Products 101 155 -35.0% 2,222 3,419 -35.0% 99 -25.2% 18,940 -24.8%   Commodity Products 77 52 47.8% 1,692 1,145 47.8% 63 34.2% 12,128 34.9%   U.S. Derivatives Products (contracts in thousands)   Equity Options 3   NYSE Group Options Contracts 3,473 2,998 15.9% 72,928 62,948 15.9% 3,652 46.9% 686,605 46.9% Total Consolidated Options Contracts 13,319 13,993 -4.8% 279,696 293,863 -4.8% 14,040 3.8% 2,639,548 3.8%   NYSE Group Share of Total 26.1% 21.4% 26.1% 21.4% 26.0% 7.6% 26.0% 7.6%   NYSE Liffe U.S.   Futures and Futures Options Volume 10.8 20.6 -47.3% 227 432 -47.3% 16.6 0.3% 3,122.6 0.3%   European Cash Products (trades in thousands) 1,399 1,475 -5.2% 30,770 32,443 -5.2% 1,483 7.3% 284,733 7.9%   Equities 1,341 1,420 -5.5% 29,508 31,241 -5.5% 1,424 7.6% 273,348 8.2% Exchange-Traded Funds 17 14 19.5% 369 309 19.5% 18 26.7% 3,432 27.4% Structured Products 35 35 1.0% 770 762 1.0% 36 -8.7% 6,844 -8.2% Bonds 6 6 -5.9% 124 131 -5.9% 6 3.1% 1,108 3.6%   U.S. Cash Products (shares in millions) 5 2,278 3,021 -24.6% 47,829 63,446 -24.6% 2,719 -22.8% 511,225 -22.8%   NYSE Listed (Tape A) Issues 4   NYSE Group Handled Volume 5 1,625 2,249 -27.7% 34,134 47,238 -27.7% 1,972 -23.2% 370,774 -23.2% NYSE Group Matched Volume 6 1,547 2,054 -24.7% 32,477 43,132 -24.7% 1,848 -20.7% 347,375 -20.7% Total NYSE Listed Consolidated Volume 4,026 5,686 -29.2% 84,545 119,414 -29.2% 5,053 -15.7% 949,963 -15.7%   Share of Total Consolidated Volume Handled Volume 5 40.4% 39.6% 0.8% 40.4% 39.6% 0.8% 39.0% -3.8% 39.0% -3.8% Matched Volume 6 38.4% 36.1% 2.3% 38.4% 36.1% 2.3% 36.6% -2.3% 36.6% -2.3%   NYSE Arca & Amex (Tape B) Listed Issues   NYSE Group Handled Volume 5 339 402 -15.7% 7,118 8,447 -15.7% 406 -28.1% 76,244 -28.1% NYSE Group Matched Volume 6 311 348 -10.7% 6,525 7,308 -10.7% 364 -26.3% 68,405 -26.3% Total NYSE Arca & Amex Listed Consolidated Volume 1,229 1,541 -20.2% 25,812 32,357 -20.2% 1,534 -24.9% 288,405 -24.9%   Share of Total Consolidated Volume Handled Volume 5 27.6% 26.1% 1.5% 27.6% 26.1% 1.5% 26.4% -1.2% 26.4% -1.2% Matched Volume 6 25.3% 22.6% 2.7% 25.3% 22.6% 2.7% 23.7% -0.4% 23.7% -0.4%   Nasdaq Listed (Tape C) Issues   NYSE Group Handled Volume 5 313 370 -15.2% 6,577 7,760 -15.2% 342 -12.4% 64,206 -12.4% NYSE Group Matched Volume 6 272 295 -7.7% 5,714 6,191 -7.7% 287 -9.7% 54,021 -9.7% Total Nasdaq Listed Consolidated Volume 2,021 2,411 -16.2% 42,447 50,627 -16.2% 2,294 -0.2% 431,299 -0.2%   Share of Total Consolidated Volume Handled Volume 5 15.5% 15.3% 0.2% 15.5% 15.3% 0.2% 14.9% -2.1% 14.9% -2.1% Matched Volume 6 13.5% 12.2% 1.3% 13.5% 12.2% 1.3% 12.5% -1.3% 12.5% -1.3%   Exchange-Traded Funds 5,7   NYSE Group Handled Volume 5 329 364 -9.6% 6,906 7,638 -9.6% 392 -29.6% 73,607 -29.6% NYSE Group Matched Volume 6 301 317 -5.0% 6,322 6,656 -5.0% 352 -27.8% 66,172 -27.8% Total ETF Consolidated Volume 1,214 1,461 -16.9% 25,501 30,679 -16.9% 1,518 -26.6% 285,403 -26.6%   Share of Total Consolidated Volume Handled Volume 5 27.1% 24.9% 2.2% 27.1% 24.9% 2.2% 25.8% -1.1% 25.8% -1.1% Matched Volume 6 24.8% 21.7% 3.1% 24.8% 21.7% 3.1% 23.2% -0.4% 23.2% -0.4%

 

1 Data includes currency products. 2 Includes all trading activities for Bclear, NYSE Liffe's clearing service for wholesale derivatives. 3 Includes trading in U.S. equity options contracts, not equity-index options. 4 Includes all volume executed in NYSE Group crossing sessions. 5 Represents the total number of shares of equity securities and ETFs internally matched on the NYSE Group's exchanges or routed to and executed at an external market center. NYSE Arca routing includes odd-lots. 6 Represents the total number of shares of equity securities and ETFs executed on the NYSE Group's exchanges. 7 Data included in previously identified categories.

 

Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as reported for equity securities.

 

All trading activity is single-counted, except European cash trading which is double counted to include both buys and sells.